Drugs / Lipanthyl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03586674 | Nov 2017 → Jun 2018 | cholestasis | Hoda A. Atta | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lipanthyl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03586674 ↗ |
| Route | Oral | “lipanthyl 10-20 mg/kg/d by mouth” NCT03586674 ↗ |